Ignite Creation Date:
2024-05-06 @ 4:28 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04993378
Status:
UNKNOWN
Last Update Posted:
2021-08-06
First Post:
2021-07-29
Brief Title:
Prospectively Predict the Efficacy of Treatment of Gastrointestinal Tumors Based on Peripheral Multi-omics Liquid Biopsy
Sponsor:
Shen Lin
Organization:
Peking University
Study Overview
Official Title:
A Clinical Study Initiated by InvestigatorProspectively Predict the Efficacy of Precise Treatment of Gastrointestinal Tumors Based on Peripheral Blood Multi-omics Liquid Biopsy
Status:
UNKNOWN
Status Verified Date:
2021-08
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To vertify the function of EV-score on predicting monitoring immunotherapeutic outcomes of GC
Detailed Description:
Our previous work identified four plasma EV-derived proteins and combined them to generate a signature score that robustly predicting immunotherapeutic outcomes at baseline and dynamically monitoring disease progressions along with the whole treatment
Hence in this stuty we plan to recruit a prospective cohort to support our conclusions and provide possible method to realize predicting and monitoring immunotherapeutic outcomes of GC
Hence in this stuty we plan to recruit a prospective cohort to support our conclusions and provide possible method to realize predicting and monitoring immunotherapeutic outcomes of GC
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None